A standalone M&A theme involving the acquisition of 100% of TPC Holdings, thereby securing a North American C4 chemicals business platform and butadiene production capacity. As part of the portfolio reorganization under the Fourth Medium-Term Management Plan, the company aims to rank among the world’s top three in butadiene production capacity.